SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-20-019033
Filing Date
2020-06-05
Accepted
2020-06-05 17:24:36
Documents
1
Period of Report
2020-06-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 2777
  Complete submission text file 0001127602-20-019033.txt   4449
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Issuer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O CELL GENESYS, INC. 500 FORBES BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
SHERWIN STEPHEN A (Reporting) CIK: 0001079462 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 000-19311 | Film No.: 20947390